Pictet Asset Management (UK)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-96,390
| Closed | -$3.63M | – | 1878 |
|
2021
Q1 | $3.63M | Buy |
+96,390
| New | +$3.63M | ﹤0.01% | 889 |
|
2018
Q2 | – | Sell |
-417,313
| Closed | -$7.17M | – | 919 |
|
2018
Q1 | $7.17M | Sell |
417,313
-9,739
| -2% | -$167K | 0.02% | 579 |
|
2017
Q4 | $9.36M | Sell |
427,052
-41,036
| -9% | -$900K | 0.02% | 523 |
|
2017
Q3 | $19.2M | Buy |
468,088
+158,863
| +51% | +$6.5M | 0.05% | 371 |
|
2017
Q2 | $8.74M | Buy |
309,225
+65,550
| +27% | +$1.85M | 0.03% | 496 |
|
2017
Q1 | $8.81M | Buy |
243,675
+67,163
| +38% | +$2.43M | 0.03% | 491 |
|
2016
Q4 | $8.85M | Buy |
176,512
+19,793
| +13% | +$992K | 0.03% | 469 |
|
2016
Q3 | $8.23M | Buy |
+156,719
| New | +$8.23M | 0.03% | 466 |
|